Caribou Biosciences, Inc. (CRBU) NASDAQ

1.80

-0.01(-0.55%)

Updated at December 20 04:00PM

Currency In USD

Valuation

Market Cap422.92M
Enterprise Value398.86M
P/E Ratio-1.1
PEG Ratio0.06
Price/Sales Ratio14.2
Price/Book Ratio0.58
Enterprise/Revenue13.74
Enterprise/EBITDA-0.97

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-12.91
Operating Margin-14.4

Management Effectiveness

Return On Assets-0.43
Return On Equity-0.45

Income Statement

Revenue34.48M
Revenue/Share0.13
Gross Profit-77.6M
EBITDA-112.53M
Net Income-102.07M
Diluted EPS-1.38

Balance Sheet

Total Cash228.18M
Total Cash/Share2.52
Total Debt26.64M
Total Debt/Equity0
Current Ratio7.38
Book Value Per Share3.11

Price History

52-Week Change-70.83
52-Week High8.33
52-Week Low1.5
Moving Average 50 Days2.08
Moving Average 200 Days2.7

Statistics

Average Volume1.33M
Shares Outstanding90.55M
% Held by Institutions57.9

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A